skip to context

Pharmacovigilance Evaluation

This evaluation form has been put together by the Adis Pharmacovigilance team to assess the effectiveness of your existing processes for pharmacovigilance literature monitoring.

Answer the following questions

 Please answer the following questions below as fully as possible.
Q1. Which sources do you currently monitor for pharmacovigilance purposes? (check all that apply)
Q4. Do you outsource any steps of the literature monitoring process?
Q5. Do you have a way of receiving alerts or data on JUST case reports published on your marketed substances?
Q7. Are you using a safety database, whether it is your own or a commercially available one? (if no, please skip to question 10)
Q8. Is this database accepting E2B records? (if no, please skip to question 10)
Q10. Which regulators do you have to submit ICSRs (case reports) to?
Q11. Which of the following do you require literature monitoring for:
Q12. Do you also cover non-reportable cases in your ICSR monitoring?
About You
Thank you for taking the time to complete our evaluation. Once we have received your evaluation, we will review and get back to you with our recommendations. By completing this form, you are agreeing to us contacting you to discuss your requirements. We also use the information you supply in this form to help us understand more about our customers and their interests, and may also contact you from time-to-time to let you know about relevant new services and offers available from Adis and the wider Springer organization. We promise not to distribute or sell your information to any third parties outside of the Springer group. You are free to opt out or amend your contact preferences at any time by emailing unsubscribe@adis.com
Privacy Policy *

We collect and use your personal data to facilitate the information you requested. As we describe in our privacy policy, we won’t contact you for anything not related to this request and we will not share your information with any third parties. We may share it with our affiliated companies and use it internally for analysis purposes.

* required field